Join us on December 14 for our Patient-Focused Sessions on Multiple Myeloma, taking place in Charlotte, NC! 

×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Events
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Lung Cancer

Sarah Christ
When others assume that patients with lung cancer must have smoked to get the disease, this stigma can affect patient outcomes.
 
Kristie L. Kahl
The Food and Drug Administration approved Tecentriq in combination with chemotherapy for the first-line treatment of adults with metastatic non-squamous non-small cell lung cancer without EGFR or ALK mutations.
 
Kristie L. Kahl
The FDA accepted a supplemental biologics license application (sBLA) and granted a priority review to Imfinzi (durvalumab) for the treatment of patients with previously untreated extensive-stage small cell lung cancer (SCLC), according to AstraZeneca, the drug’s manufacturer.
Kelly Clark, MA
There is plenty of scientific data about the physical challenges patients with cancer endure, but more is needed to address psychosocial issues.
Conor Killmurray
Patient advocate and lung cancer survivor Nancy Cohen discusses living with stage 4 lung cancer.
Katie Kosko and Jessica Skarzynski
Here’s a look at what’s inside our November 2019 Lung Cancer special issue.
Katie Kosko
How one mother learned that “broken hearts still beat.”
Deborah Abrams Kaplan
New therapies offer options for patients with non-small cell lung cancer whose disease has spread to the brain.
Debu Tripathy, M.D.
Paraneoplastic syndromes are uncommon disorders that can arise with any cancer type but are more common with lung cancer.
Mike Hennessy, Sr.
New therapies approved following innovative research are increasing survival rates for patients with advanced lung cancer. 
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×